News
News Releases
Elix and Axcelead DDP Enter into Collaborative Research Agreement to Advance Targeted Protein Degrader Discovery: Combining AI Drug Discovery Technologies with Drug Discovery Expertise to Advance Solutions for Challenging Targets
Tokyo and Fujisawa, Japan, September 9, 2026 – Elix, Inc. (Headquarters: Chiyoda-ku, Tokyo; hereinafter “Elix”) and Axcelead...
Notice Regarding Unauthorized Access to an Employee Email Account
Fujisawa, Japan – July 22, 2026 – We have confirmed that a third party gained unauthorized access...
Axcelead DDP Joins Lilly TuneLab to Advance AI Drug Discovery
Fujisawa, Japan, June 18, 2026 — Axcelead Drug Discovery Partners, Inc. (Axcelead DDP) is pleased to announce...
Proteros and Axcelead DDP Enter Strategic Collaboration to Enhance Discovery Capabilities
Proteros and Axcelead DDP Enter Strategic Collaboration to Enhance Discovery Capabilities Axcelead gains access to Proteros’ capabilities...
Nissan Chemical and Axcelead DDP Enter into License Agreement for DNA-Encoded Library (DEL)
Tokyo and Fujisawa, Japan – February 24, 2026 – Nissan Chemical Corporation (Headquarter: Tokyo, Japan;...